Industry

Recent Study on Computationally-Guided Intranasal Spray Protocol to Augment Therapeutic Penetration With Implications Shown for Effective Treatments for COVID-19, Rhinitis, and Sinusitis AMERICAN FORK, Utah–(BUSINESS WIRE)–#nasal–Today Xlear announced a new partnership with Dr. Ferrer BioPharma (DFBP), which will make Xlear nasal spray the first nasal hygiene tool to deploy the GentleMist nozzle—the next generation nasal … [Read more…]

After an extensive environmental study, The New Bedford Housing Authority added UV Angel Clean Air™ units to the Boa Vista Tower to make community activities safer for residents. NEW BEDFORD, Mass.–(BUSINESS WIRE)–UV Angel, a health and technology company that harnesses the power of Upper-Room Ultraviolet Germicidal Irradiation (UVGI) to make environments measurably safer, today announced … [Read more…]

Annual awards program recognizes outstanding health and medical technology products and companies MORRISVILLE, N.C.–(BUSINESS WIRE)–NantHealth, Inc. (NASDAQ: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that its NaviNet Open platform has been selected as the winner of the “Healthcare Insurance Innovation Award” in the sixth … [Read more…]

Workforce Solutions Talent Platform Earns 2022 Top Workplaces Culture Excellence Awards BOCA RATON, Fla.–(BUSINESS WIRE)–Cross Country Healthcare, Inc. (CCH), a market-leading workforce solutions, tech-enabled talent platform, and staffing and advisory services firm, announced today that it has earned the 2022 Top Workplaces Culture Excellence award for Leadership and Innovation. “We are immensely proud of this … [Read more…]

–Forte Biosciences to Develop Novel Pipeline for the Treatment of Autoimmune Diseases– -Leadership Strengthened with Appointments of Stephen Doberstein, Ph.D. and Barbara Finck, M.D. to the Board of Directors- -Ended first quarter 2022 with approximately $40.0 million in cash and cash equivalents- DALLAS–(BUSINESS WIRE)–Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune … [Read more…]

— Company Continues to Successfully Advance Product Candidates — BERWYN, Pa.–(BUSINESS WIRE)–#earnings—Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the quarter ended March 31, 2022, and other recent developments. “We continue to make excellent progress with all of our drug product candidates,” stated Anthony P. Mack, Chairman and Chief … [Read more…]

PARSIPPANY, N.J.–(BUSINESS WIRE)–IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Pravin U. Dugel, M.D., President, will present a corporate overview at the H.C. Wainwright Global Investment Conference, being held from May 23-26, 2022. The on-demand presentation will be available for viewing beginning Tuesday, May 24 at 7:00 a.m. ET and can be accessed on the … [Read more…]

ANN ARBOR, Mich.–(BUSINESS WIRE)–$NDRA #NALFD—ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, announces that management will present a company overview at the H.C. Wainwright Global Investment Conference being held May 23-26, 2022 in Miami Beach and will be holding virtual one-on-one meetings. A webcast of the presentation will be available on-demand … [Read more…]

Poster to highlight lead therapeutic candidates, a series of fully personalized T cell therapies WATERTOWN, Mass.–(BUSINESS WIRE)–RootPath, a synthetic biology company that elevates the throughput of gene function interrogation by orders of magnitude, today announced that a poster presentation highlighting its lead therapeutic candidates, a series of fully personalized T cell therapies, at the American … [Read more…]

– Results from pharmacokinetic (PK) similarity study demonstrate bioequivalence of AVT04 (ustekinumab) to the reference product Stelara® REYKJAVIK, Iceland–(BUSINESS WIRE)–Alvotech Holdings S.A. (“Alvotech”), a global biotech company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, today announced positive top-line results from a pharmacokinetic (PK) study for AVT04, Alvotech’s proposed biosimilar … [Read more…]